Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
18.26 USD | +1.50% | +1.00% | -20.71% |
04-22 | Citigroup Starts Privia Health Group With Buy Rating, $25 Price Target | MT |
03-19 | Canaccord Genuity Adjusts Privia Health Group Price Target to $37 From $41, Maintains Buy Rating | MT |
Evolution of the average Target Price on Privia Health Group, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Privia Health Group, Inc.
Citigroup | |
Canaccord Genuity | |
JPMorgan Chase | |
Barclays | |
UBS | |
TD Cowen | |
Truist Securities | |
RBC Capital Markets | |
JMP Securities | |
Evercore ISI | |
Stephens Inc. | |
Goldman Sachs | |
Stifel Nicolaus | |
Credit Suisse | |
Guggenheim | |
Cowen | |
SVB Securities LLC | |
BofA Securities | |
BTIG | |
Piper Sandler | |
SVB Leerink | |
Jefferies & Co. | |
William Blair & Co. | |
J.P. Morgan Chase |
EPS Revisions
- Stock Market
- Equities
- PRVA Stock
- Consensus Privia Health Group, Inc.